

Column Agglutination Test Cards Market Scope:
Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The Column Agglutination Test Cards market is experiencing significant growth, driven by increasing demand for rapid and accurate blood typing. The global market size is projected to reach USD 200 million by 2026, reflecting advancements in diagnostic technologies and expanding applications in transfusion medicine, immunology, and infectious disease testing.
◍ Grifols
◍ Bio-Rad
◍ Ortho Clinical Diagnostics (QuidelOrtho)
◍ Turklab
◍ Tulip Diagnostics (PerkinElmer)
◍ Redcell Biotechnology
◍ Dia Pro Tıbbi Ürünler
◍ Aikang MedTech
◍ Tianjin Dexiang Biotech
◍ POLYRICHE BIOTECH
◍ Hubei Longtime Biological
◍ Singapore BioSciences
The Column Agglutination Test Cards Market is competitive, with companies like Grifols, Bio-Rad, and Ortho Clinical Diagnostics leading. These firms enhance market growth through innovative product offerings and strategic partnerships. Their contributions include improved diagnostic accuracy and efficiency. Notable sales figures include Grifols: $2 billion, Bio-Rad: $2.3 billion. Request Sample Report
Hospitals
Research Centers
Laboratory
Others
◍ Blood Grouping Forward and Reverse Test
Cross Match Test
Other
Request Sample Report
Request Sample Report
$ X Billion USD